Status:
COMPLETED
MAFLD-simplified Definition as an Optimized Risk Stratification Tool for Predicting Metabolic Outcomes
Lead Sponsor:
Ningbo No. 1 Hospital
Conditions:
Metabolic Associated Fatty Liver Disease
Eligibility:
All Genders
18-100 years
Brief Summary
Recently, a consensus was proposed by an international expert panel for the terminology changed from NAFLD to Metabolic associated fatty liver disease (MAFLD). The comprehensive criteria shift to a "p...
Detailed Description
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver diseases. It affects nearly 25% of the global population. Recently, a consensus was proposed by an international expe...
Eligibility Criteria
Inclusion
- diagnosed ad fatty liver by ultrasound
Exclusion
- Missing data on Ultrasound, blood glucose, BMI and metabolic status.
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
3372 Patients enrolled
Trial Details
Trial ID
NCT04761900
Start Date
January 1 2012
End Date
December 31 2020
Last Update
February 21 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.